From August 1, 2022 to September 30, 2022, the company has repurchased 274,400 shares, representing 0.73% for ¥933.83 million. With this, the company has completed the repurchase of 274,400 shares, representing 0.73% for ¥933.83 million under the buyback announced on August 1, 2022.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3,150 JPY | -2.48% | -1.72% | -3.67% |
04-25 | Hidehiro Imatsu named president of Goldman Sachs Japan | RE |
03-21 | Tranche Update on Mochida Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 15, 2023. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.67% | 735M | |
+30.38% | 684B | |
+29.15% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.85% | 240B | |
+9.13% | 208B | |
-7.85% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- 4534 Stock
- News Mochida Pharmaceutical Co., Ltd.
- Tranche Update on Mochida Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on August 1, 2022.